
Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

